本文選題：膽總管結(jié)石 + ERBD術(shù)�。� 參考：《河南中醫(yī)》2017年05期

【摘要】：目的:觀察利膽消石顆粒聯(lián)合膽道塑料支架置入術(shù)(ERBD)治療膽總管巨大結(jié)石的臨床療效。方法:選取52例膽總管巨大結(jié)石的梗阻性黃疸患者,隨機(jī)分為對(duì)照組25例和治療組27例,對(duì)照組僅行ERBD術(shù),治療組行ERBD術(shù)后加用利膽消石顆粒口服,比較兩組術(shù)后膽紅素消退情況,以及3個(gè)月后再次行ERCP取石的成功率。結(jié)果:治療3 d后,兩組TBIL比較無(wú)顯著統(tǒng)計(jì)學(xué)意義(P0.05);治療后1周,兩組TBIL比較有統(tǒng)計(jì)學(xué)意義(P0.05)。3個(gè)月后再次行ERCP取石成功率治療組優(yōu)于對(duì)照組,差異均有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論:利膽消石顆粒聯(lián)合ERBD術(shù)可有效解除膽總管巨大取石引起的梗阻性黃疸,并可提高二次取石的成功率,療效確切。
[Abstract]:Objective: to observe the clinical effect of Lidanxiaoshi granule combined with plastic biliary stent implantation in the treatment of giant choledocholithiasis. Methods: 52 patients with obstructive jaundice with huge common bile duct stones were randomly divided into control group (n = 25) and treatment group (n = 27). The control group was treated with ERBD only and the treatment group was treated with Lidanxiaoshi granule after ERBD. The bilirubin regression was compared between the two groups, and the success rate of ERCP lithotomy 3 months later was compared. Results: after 3 days of treatment, there was no significant difference in TBIL between the two groups (P 0.05), but one week after treatment, there was a significant difference in TBIL between the two groups (P 0.05). After 3 months, the success rate of ERCP lithotomy in the treatment group was better than that in the control group, and the difference was statistically significant (P 0.05). Conclusion: Lidanxiaoshi granule combined with ERBD can effectively relieve obstructive jaundice caused by huge choledocholithiasis and increase the success rate of secondary lithotomy.
【作者單位】： 河南中醫(yī)藥大學(xué)第一附屬醫(yī)院;
【基金】：河南省科技廳科技攻關(guān)項(xiàng)目(編號(hào):132102310493)
【分類(lèi)號(hào)】：R657.42

【相似文獻(xiàn)】

相關(guān)期刊論文 前1條

1 宗愛(ài)妹;“消石利膽湯”治療膽結(jié)石32例[J];江西中醫(yī)藥;1997年05期

，

本文編號(hào)：1799492